Investors with a lot of money to spend have taken a bullish stance on Humana HUM.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HUM, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 14 uncommon options trades for Humana.
This isn't normal.
The overall sentiment of these big-money traders is split between 57% bullish and 42%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $1,363,000, and 7 are calls, for a total amount of $1,102,605.
Latest Startup Investment Opportunities:
What's The Price Target?
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $310.0 to $400.0 for Humana during the past quarter.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Humana's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Humana's whale activity within a strike price range from $310.0 to $400.0 in the last 30 days.
Humana Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| HUM | PUT | TRADE | BULLISH | 04/19/24 | $310.00 | $752.3K | 101 | 1.6K |
| HUM | CALL | SWEEP | BULLISH | 04/26/24 | $330.00 | $371.9K | 0 | 320 |
| HUM | CALL | SWEEP | BULLISH | 04/26/24 | $330.00 | $357.7K | 0 | 159 |
| HUM | PUT | TRADE | BEARISH | 04/19/24 | $330.00 | $306.0K | 592 | 304 |
| HUM | CALL | SWEEP | BULLISH | 04/26/24 | $335.00 | $225.2K | 0 | 30 |
About Humana
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Where Is Humana Standing Right Now?
- Currently trading with a volume of 647,426, the HUM's price is down by -0.31%, now at $338.02.
- RSI readings suggest the stock is currently may be oversold.
- Anticipated earnings release is in 48 days.
What The Experts Say On Humana
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $356.0.
- Reflecting concerns, an analyst from Barclays lowers its rating to Equal-Weight with a new price target of $356.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Humana options trades with real-time alerts from Benzinga Pro.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
